The agreement includes the supply of gadobutrol injection, a generic version of Gadavist, and gadoterate meglumine injection, ...

Zydus Lifesciences announced that its wholly owned subsidiary, Zydus Lifesciences Global FZE has entered into an exclusive licensing and supply agreement with Viwit Pharmaceuticals (Viwit), an ...

Ahmedabad: Zydus Lifesciences Ltd., a global innovation driven healthcare company has announced that its wholly owned ...

Zydus' agreement with Viwit Pharmaceuticals covers the supply of gadobutrol and gadoterate meglumine injections, widely used ...

Viwit will handle manufacturing and supply of the injectables, while Zydus Lifesciences will "exclusively market, distribute" and sell them.